Harnessing the power of epigenomics combined with advanced AI on clinical samples, we propel your biomarker discovery to a new dimension.
Leveraging our expertise in cutting-edge techniques, methodologies and platforms, we identify biomarkers with unprecedent precision.
Partner with us to experience a comprehensive journey with streamlined timelines, from R&D to clinical trials, accelerating your path to market.
*Note: Epigenomic testing services are research use only and do not necessarily comply with all CLIA requirements.
Our comprehensive approach can be tailored to create an end-to-end service that matches your specific needs. Below is a sampling of our core technologies that help you discover new insights through epigenomics to accelerate your biomarker discovery and validation for early detection, patient screening, MRD and much more.
